We came across a bullish thesis on Eli Lilly and Company on Stock Analysis Compilation’s Substack. In this article, we will ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...

In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

Analysts' ratings for Eli Lilly and Co (NYSE:LLY) over the last quarter vary from bullish to bearish, as provided by 17 analysts.The table below summarizes their recent ratings, showcasing the ...

Fool.com contributor Parkev Tatevosian discusses the prospects for Eli Lilly stock. *Stock prices used were the afternoon prices of June 14, 2024. The video was published on June 16, 2024.

Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

I recommend buying Eli Lilly and Company stock after strong Q2 earnings, with technical indicators pointing to upward momentum. Click for more on LLY stock.

Bernstein SocGen Group has reiterated an Outperform rating and $1,100.00 price target on Eli Lilly (NYSE: LLY) ahead of the American Diabetes Association’s 85th Annual meeting.Currently trading ...

Analyst Mohit Bansal from Wells Fargo maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and keeping the price target at $875.00. Mohit Bansal has given his Buy rating due to a ...

Eli Lilly Stock Soars on Oral Weight-Loss Drug Trial Results Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly Watch These Coinbase Price Levels After Stock's 20% Drop in ...

On Monday, Eli Lilly And Co (NYSE:LLY) announced results from the Phase 3 BRUIN CLL-321 trial evaluating pirtobrutinib in adult patients with chronic lymphocytic leukemia or small lymphocytic ...